A Day Up For Celyad SA

Celyad SA (CYAD:NASDAQ) jumped higher at $4.7, representing a gain of 29.1%. On Thu, Dec 02, 2021, CYAD:NASDAQ hit a New 2-Week Low of $3.56. The stock appeared on our News Catalysts scanner on Fri, Dec 03, 2021 at 03:03 AM in the 'PRIVATE PLACEMENT' category. From Thu, Nov 18, 2021, the stock recorded 22.22% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Celyad SA (CYAD:NASDAQ)

Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.